Top Markets
Coin of the day
American CryoStem Corporation American CryoStem Corporation

American CryoStem Corporation

CRYO
Ранг среди акций #42083
American CryoStem Corporation (ACSC) specializes in the development,... American CryoStem Corporation (ACSC) specializes in the development, commercialization, and licensing of technologies derived from adipose (fat) tissue, primarily for applications within regenerative and personalized medicine. Among its key offerings is the CELLECT system, designed to streamline tissue sample collection, transportation, and storage for medical practitioners. The company also provides the ATGRAFT service, a comprehensive solution for harvesting, processing, and preserving adipose tissue, enabling physicians to offer patients versatile options for tissue products and cellular banking. Complementing these are ATCELL, a line of proprietary adipose-derived stem cells, and ACSelerat cell culture media, specifically formulated to promote the growth of human stromal cells. Furthermore, American CryoStem extends its expertise through contract manufacturing services for specific formulations, including Autokine-CM, an anti-aging topical product, and a unique autologous skin care range. Founded in 1987, American CryoStem Corporation is headquartered in Eatontown, New Jersey.
Цена акции
$0.0001
Последняя синхронизация: 2024-04-02
Рыночная капитализация
$5.03K
Изменение (1 день)
0.00%
Изменение (1 год)
0.00%
Страна
US
Торговля American CryoStem Corporation (CRYO)

Категория

Коэффициент P/B для American CryoStem Corporation (CRYO)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций American CryoStem Corporation, текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для American CryoStem Corporation с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.2613 -
US
6.3483 -
NL
- -
CH
3.634 -
BE
- -
KR